Galpharma None

Galpharma is a Japanese company founded in 2000 that focuses on researching and developing sugar chain-binding proteins, particularly galectin 9. Their goal is to provide pharmaceutical companies with information on the functional analysis of these proteins in various diseases and substances, as well as optimized drug candidates to fight these diseases.


Invests into


Connections

Headquarters: Takamatsu-shi, Kagawa, Japan
Estimated Revenue: about 1.25 trillion US dollars
Founded Date: 2000